Bone loss after childhood acute lymphoblastic leukaemia: An observational study with and without GH therapy

European Journal of Endocrinology

Volumn 164, Issue 5, 2011, Pages 695-703

  Follin, Cecilia ^a   Link, Katarina ^a   Wiebe, Thomas ^a   Moëll, Christian ^a   Björk, Jonas ^a   Erfurth, E M ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; DEXAMETHASONE; ESTROGEN; GROWTH HORMONE; METHOTREXATE; OSTEOCALCIN; PREDNISOLONE; SOMATOMEDIN C; TESTOSTERONE; THYROTROPIN; HUMAN GROWTH HORMONE; PROSTAGLANDIN E2;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; ANTHROPOMETRY; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; BONE DENSITY; BONE TURNOVER; CALCIUM INTAKE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; ESTROGEN BLOOD LEVEL; EXERCISE; FEMALE; FEMUR NECK; GROWTH HORMONE DEFICIENCY; HORMONE DETERMINATION; HORMONE SUBSTITUTION; HUMAN; MALE; OBSERVATIONAL STUDY; OSTEOLYSIS; PRIORITY JOURNAL; RADIATION DOSE; TESTOSTERONE BLOOD LEVEL; THYROTROPIN BLOOD LEVEL; CASE CONTROL STUDY; COMPARATIVE STUDY; DRUG EFFECT; FOLLOW UP; METABOLISM; PHYSIOLOGY; CANCER COMBINATION CHEMOTHERAPY; CHILDHOOD CANCER; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG DOSE TITRATION; HORMONAL THERAPY; LOW DRUG DOSE; OSTEOPOROSIS; OUTCOME ASSESSMENT; RISK FACTOR; THERAPY EFFECT; TREATMENT DURATION;

ADULT; BONE DENSITY; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMAN GROWTH HORMONE; HUMANS; MALE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; YOUNG ADULT;

EID: 79955525983     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-10-1075     Document Type: Article

References (36)

1. Oeffinger KC, Eshelman DA, Tomlinson GE, Tolle M & Schneider G. Providing primary care for long-term survivors of childhood acute lymphoblastic leukemia. Journal of Family Practice 2000 49 1133-1146. (Pubitemid 32003447)
2. Robson H, Anderson E, Eden O, Isaksson O & Shalet S. Chemotherapeutic agents used in the treatment of childhood malignancies have a direct effects on growth plate chondrocyte proliferation. Journal of Endocrinology 1998 157 225-235. (doi:10.1677/joe.0.1570225)
3. Sala A & Barr R. Osteopenia and cancer in children and adolescents. Cancer 2007 109 1420-1431. (doi:10.1002/cncr.22546)
4. Brennan BMD, Rahim A & Mackie EM. Growth hormone status in adults treated for acute lymphoblastic leukaemia in childhood. Clinical Endocrinology 1998 48 777-783. (doi:10.1046/j.1365-2265.1998.00438.x)
5. Link K, Moëll C, Garwicz S, Cavallinj-Ståhl E, Björk J, Thilén U, Ahrén B & Erfurth EM. Growth hormone deficiency predicts cardiovascular risk in young adults treated for acute lymphoblastic leukaemia in childhood. Journal of Clinical Endocrinology and Metabolism 2004 89 5005-5012. (doi:10.1210/jc.2004-0126)
6. Kaufman JM, Taelman P, Vermeulen A & Vandeweghe M. Bone mineral status in growth hormone-deficient males with isolated and multiple pituitary deficiencies of childhood onset. Journal of Clinical Endocrinology and Metabolism 1992 74 118-123. (doi:10.1210/jc.74.1.118)
7. Saggese G, Baroncelli B, Bertelloni S & Barsanti S. The effect of long-term growth hormone (GH) treatment on bone mineral density in children with GH deficiency. Role of GH in the attainment of peak bone mass. Journal of Clinical Endocrinology and Metabolism 1996 81 3077-3088. (doi:10.1210/jc.81.8. 3077)
8. Drake WM, Caroll P, Maher K, Metcalfe A, Camacho-Hü bner C, Shaw N, Dunger T, Cheetham T, Savage M & Monson J. The effect of cessation of growth hormone (GH) therapy on bone mineral accretion in GH-deficient adolescents at the completion of linear growth. Journal of Clinical Endocrinology and Metabolism 2003 88 1658-1663. (doi:10.1210/jc.2002-021541)
9. Shalet S, Shavrikova E, Cromer M, Child C, Keller E, Zapletalova J, Moshang T, Blum W, Chipman J, Quigley C & Attanasio A. Effects of growth hormone (GH) treatment on bone in postpubertal GH-deficient patients: a 2-years randomized, controlled, dose-ranging study. Journal of Clinical Endocrinology and Metabolism 2003 88 4124-4129. (doi:10.1210/jc.2003-030126)
10. Katzman D, Bachrach L, Carter D & Marcus R. Clinical and anthropometric correlates of bone mineral acquisition in healthy adolescent girls. Journal of Clinical Endocrinology and Metabolism 1991 73 1332-1339. (doi:10.1210/jcem-73-6-1332)
11. Gilsanz V, Carlsson M, Roe T & Ortega J. Osteoporosis after cranial irradiation for acute lymphoblastic leukemia. Journal of Pediatrics 1990 117 238-244. (doi:10.1016/S0022-3476(05)80536-0)
12. Nussey S, Hyer S, Brada M & Leiper AD. Bone mineralization after treatment of growth hormone deficiency in survivors of childhood malignancy. Acta Paediatrica 1994 399 9-14. (doi:10.1111/j.1651-2227.1994.tb13276.x)
13. Nysom K, Holm K, Michaelsen K, Hertz H, Müller J & Mölgaard C. Bone mass after treatment for acute lymphoblastic leukaemia in childhood. Journal of Clinical Oncology 1998 12 3752-3760. (Pubitemid 29001526)
14. Hoorweg-Nijman J, Kardos G, Roost J, van Dijk H, Netelenbost C, Popp-Snijders C, de Ridder C & Delemarre-van de Waal H. Bone mineral density and markers of bone turnover in young adult survivors of childhood lymphoblastic leukemia. Clinical Endocrinology 1999 50 237-244. (doi:10.1046/j.1365-2265.1999.00654.x)
15. Brennan BMD, Rahim A, Adams J, Eden O & Shalet S. Reduced bone mineral density in young adults following cure of acute lymphoblastic leukaemia in childhood. British Journal of Cancer 1999 79 1859-1863. (doi:10.1038/sj.bjc. 6690296)
16. Thomas I, Donohue J, Ness K, Dengel D, Baker K & Gurney J. Bone mineral density in young adult survivors of acute lymphoblastic leukaemia. Cancer 2008 113 3248-3256. (doi:10.1002/cncr.23912)
17. Jarfelt M, Fors H, Lannering B & Bjarnason R. Bone mineral density and bone turnover in young adult survivors of childhood acute lymphoblastic leukaemia. European Journal of Endocrinology 2006 154 303-309. (doi:10.1530/eje.1.02092)
18. Mandel K, Atkinson S, Barr R & Pencharz P. Skeletal morbidity in childhood acute lymphoblastic leukaemia. Journal of Clinical Oncology 2004 22 1215-1221. (doi:10.1200/JCO.2004.04.199)
19. Lewiecki EM, Watts NB, McClung MR, Petak S, Bachrach L, Shepherd J & Downs R. Official positions of the International Society for Clinical Densitometry. Journal of Clinical Endocrinology and Metabolism 2004 89 3651-3655. (doi:10.1210/jc.2004-0124)
20. Wilhelmsen L, Tibblin G & Aurell M. Physical fitness and risk of myocardial infarction. Advances in Cardiology 1976 18 217-230.
21. Ghigo E, Aimaretti G & Arvat E. Growth hormone-releasing diagnosis of growth hormone deficiency in adults. Endocrine 2001 15 29-38. (doi:10.1385/ENDO:15:1:029)
22. Corneli G, Di Somma C, Baldelli B, Rovere S, Gasco V, Croce C, Grottoli S, Maccario M, Colao A, Lombardi G, Ghigo E & Camanni F. The cut-off limits of the GH response to GH-releasing hormone - arginine test related to body mass index. European Journal of Endocrinology 2005 153 257-264. (doi:10.1530/eje.1. 01967)
23. Darzy K, Thorner M & Shalet S. Cranially irradiated adult cancer survivors may have normal spontaneous GH secretion in the presence of discordant peak GH response to stimulation tests (compensated GH deficiency). Clinical Endocrinology 2009 70 287-293. (doi:10.1111/j.1365-2265.2008.03359.x)
24. Clayton P & Shalet S. Dose dependency of time of onset of radiation-induced growth hormone deficiency. Journal of Pediatric 1991 118 226-228. (doi:10.1016/S0022-3476(05)80487-1)
25. Colao A, Di Somma C, Pivonello R, Aimaretti G, Cerbone G, Faggiano A, Corneli G, Ghigo E & Lombardi G. Bone loss is correlated to severity of growth hormone deficiency in adult patients with hypopituitarism. Journal of Clinical Endocrinology and Metabolism 1999 84 1919-1924. (doi:10.1210/jc.84.6. 1919)
26. Ohlsson C, Bengtsson BÅ, Isaksson O, Andreassen T & Slootweg M. Growth hormone and bone. Endocrine Reviews 1998 19 55-79. (doi:10.1210/er.19.1. 55)
27. Vandeweghe M, Taelman P & Kaufman J. Short end long-term effects of growth hormone treatment on bone turnover and bone mineral content in adult growth hormone-deficient males. Clinical Endocrinology 1993 39 409-415. (doi:10.1111/j.1365-2265.1993.tb02387.x)
28. Bravenboer N, Holzmann P, Ter Maaten J, Stuurman L, Roos J & Lips P. Effect of long-term growth hormone treatment on bone mass and bone metabolism in growth hormone-deficient men. Journal of Bone and Mineral Research 2005 20 1778-1784. (doi:10.1359/JBMR.050613)
29. Holmes S, Whitehouse R, Economou G, O'Halloran D, Adams J & Shalet S. Further increase in forearm cortical bone mineral content after discontinuation of growth hormone replacement. Clinical Endocrinology 1995 42 3-7. (doi:10.1111/j.1365-2265.1995.tb02591.x)
30. Underwood L, Attie K & Baptista J. Growth hormone (GH) dose - response in young adults with childhood-onset GH deficiency: a two-year, multicenter, multiple-dose, placebo-controlled study. Journal of Clinical Endocrinology and Metabolism 2003 88 5273-5280. (doi:10.1210/jc.2003-030204)
31. Mauras N, Pescowitz O, Allada V, Messig M, Wajnrajch M & Lippe B. Limited efficacy of growth hormone (GH) during transition of GH-deficient patients from adolescence to adulthood: a phase III multicenter, doubled-blind, randomized two-year trial. Journal of Clinical Endocrinology and Metabolism 2005 90 3946-3955. (doi:10.1210/jc.2005-0208)
32. Conway G, Szarras-Czapnik M, Racz K, Keller A, Chanson P, Tauber M & Zacharin M. Treatment for 24 months with recombinant human GH has a beneficial effect on bone mineral density in young adults with childhood-onset GH deficiency. European Journal of Endocrinology 2009 160 899-907. (doi:10.1530/EJE-08-0436)
33. Johansson A, Éden Engström B, Ljunghall S, Karlsson A & Burman P. Gender differences in the effects of long term growth hormone (GH) treatment on bone in adults with GH deficiency. Journal of Clinical Endocrinology and Metabolism 1999 84 2002-2007. (doi:10.1210/jc.84.6.2002)
34. Ergun-Longmire B, Mertens A, Mitby P, Qin J, Heller G, Shi W, Yasui Y, Robison L & Sklar C. Growth hormone treatment and risk of second neoplasm in the childhood cancer survivor. Journal of Clinical Endocrinology and Metabolism 2006 91 3494-3498. (doi:10.1210/jc.2006-0656)
35. Warner J, Evans W, Webb D, Bell W & Gregory J. Relative osteopenia after treatment for acute lymphoblastic leukaemia. Pediatric Research 1999 45 544-551. (doi:10.1203/00006450-199904010-00014)
36. Wheeler D, Vander Griend R, Wronski T, Miller G, Keith E & Graves J. The short- and long-term effects of methotrexate on the rat skeleton. Bone 1995 16 215-221. (doi:10.1016/8756-3282(94)00032-U)